Burshtein Gregory has filed 3 insider transactions across 1 company since July 2025.
Most recent transaction: a grant/award of 87591 shares of Entera Bio Ltd. ($ENTX) on May 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Entera Bio Ltd. | $ENTX | Burshtein Gregory | Chief of R&D | A | Ordinary Shares, par value NIS 0.0000769 per share | 87591 | $0.00 | 189,033.0000 | 47,089,814 | 86.35% | 0.19% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Burshtein Gregory | Chief of R&D | A | Ordinary Shares, par value NIS 0.0000769 per share | 26316 | $0.00 | 101,442.0000 | 37,650,179 | 35.03% | 0.07% |
| July 16, 2025 | Entera Bio Ltd. | $ENTX | Burshtein Gregory | Chief of R&D | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 37,650,179 | 9999.99% | 0.53% |